Corrigendum to "Discovery and lead optimisation of a potent, selective and orally bioavailable RARβ agonist for the potential treatment of nerve injury" [Bioorg. Med. Chem. Lett. 29(8) (2019) 995–1000]. Issue 16 (15th August 2019) - Goncalves, Maria B.; Clarke, Earl; Jarvis, Christopher I.; Kalindjian, S. Barret; Pitcher, Thomas; Grist, John; Hobbs, Carl; Carlstedt, Thomas; Jack, Julian; Brown, Jane T.; Mills, Mark; Mumford, Peter; et al.